These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 15184887)
1. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887 [TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657 [TBL] [Abstract][Full Text] [Related]
3. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma. Dalton RR; Rassidakis GZ; Atwell C; Wang S; Oyarzo MP; Medeiros LJ Hum Pathol; 2005 Jul; 36(7):806-11. PubMed ID: 16084951 [TBL] [Abstract][Full Text] [Related]
5. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner. Hsu FY; Johnston PB; Burke KA; Zhao Y Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Amin HM; Medeiros LJ; Ma Y; Feretzaki M; Das P; Leventaki V; Rassidakis GZ; O'Connor SL; McDonnell TJ; Lai R Oncogene; 2003 Aug; 22(35):5399-407. PubMed ID: 12934099 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro. Hsu FY; Zhao Y; Anderson WF; Johnston PB Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934 [TBL] [Abstract][Full Text] [Related]
9. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649 [TBL] [Abstract][Full Text] [Related]
10. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. Rust R; Blokzijl T; Harms G; Lim M; Visser L; Kamps WA; Poppema S; van den Berg A J Pathol; 2005 Aug; 206(4):445-50. PubMed ID: 15920698 [TBL] [Abstract][Full Text] [Related]
11. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion. Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494 [TBL] [Abstract][Full Text] [Related]
12. JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells. Shi X; Franko B; Frantz C; Amin HM; Lai R Br J Haematol; 2006 Oct; 135(1):26-32. PubMed ID: 16939498 [TBL] [Abstract][Full Text] [Related]
13. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma. Sjostrom C; Seiler C; Crockett DK; Tripp SR; Elenitoba Johnson KS; Lim MS Exp Hematol; 2007 Aug; 35(8):1240-8. PubMed ID: 17560012 [TBL] [Abstract][Full Text] [Related]
14. The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma. Wang P; Zhang JD; Wu F; Ye X; Sharon D; Hitt M; McMullen TP; Hegazy SA; Gelebart P; Yang J; Ma Y; Lai R Cell Signal; 2012 Oct; 24(10):1955-63. PubMed ID: 22743134 [TBL] [Abstract][Full Text] [Related]
15. Model of inhibition of the NPM-ALK kinase activity by herbimycin A. Turturro F; Arnold MD; Frist AY; Pulford K Clin Cancer Res; 2002 Jan; 8(1):240-5. PubMed ID: 11801565 [TBL] [Abstract][Full Text] [Related]
17. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma. Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283 [TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma. Rassidakis GZ; Lai R; Herling M; Cromwell C; Schmitt-Graeff A; Medeiros LJ Am J Pathol; 2004 Jun; 164(6):2259-67. PubMed ID: 15161658 [TBL] [Abstract][Full Text] [Related]
19. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Han Y; Amin HM; Franko B; Frantz C; Shi X; Lai R Blood; 2006 Oct; 108(8):2796-803. PubMed ID: 16825495 [TBL] [Abstract][Full Text] [Related]
20. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma. Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]